Benuvia Operations, LLC.
Jeff C. has extensive experience in information technology and has held various leadership roles throughout their career. Jeff started their career at Intel Corporation in 1999 as an IT Director, where they oversaw a team of developers and was responsible for delivering IT initiatives. Jeff then joined Insys Therapeutics, Inc. in 2017 as the Senior Director of Information Technology, where they led the technology strategy and managed the Agile Scrum Team. In 2018, they became the Co-President and Head of Technology at ComplexTruths, Inc., where they provided direction and leadership for the foundation. Currently, Jeff is the Head of Information Technology at Benuvia Operations, LLC., where they define the strategic IT vision for the company and leads an Agile development team. Jeff is responsible for all technical aspects of the products and communicates the architectural vision to the executive team.
Jeff C. completed their Bachelor's degree in Computer Science at Heald College from 2013 to 2015. Prior to that, they earned an Associate's Degree in Computer Science from the same institution from 1997 to 1999. In addition, they obtained the Certified Scrum Product Owner (CSPO) and Certified ScrumMaster (CSM) certifications from the Scrum Alliance in November 2020.
This person is not in any teams
This person is not in any offices
Benuvia Operations, LLC.
Benuvia Manufacturing is a leading developer and manufacturer of high-purity, pharmaceutical cannabinoid ingredients and products. We offer a comprehensive suite of solutions for pharmaceutical, biotechnology, and consumer product companies to achieve their development and commercial needs. We have over 100,000 square feet of state-of-the-art research, development and manufacturing space across two cGMP facilities in Chandler, Arizona and Round Rock, Texas. We began manufacturing pharmaceutical grade cGMP pure quality cannabidiol (CBD) in 2009 and our Round Rock facility has produced CBD since 2014 (DMF 32552). Today, Round Rock is the only CBD active pharmaceutical ingredient (API) contract manufacturing site in the U.S. producing an FDA approved cannabinoid drug (SYNDROS®). Our facilities are DEA and FDA registered cGMP production sites and are fully regulated and compliant with all DEA, EPA, and OSHA requirements. Further information is available at www.benuviamanufacturing.com.